Business Context and Reporting Period
This Form 8-K reports on the results of the 2018 Annual Meeting of Stockholders for AcelRx Pharmaceuticals, Inc. (noted as TALPHERA, INC. in metadata), held on June 14, 2018. The filing details the election of directors and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
There were 51,037,023 shares of common stock entitled to vote, with 42,742,542 shares represented at the meeting. The following proposals were approved:
- Proposal No. 1 (Election of Directors): Adrian Adams, Richard Afable, M.D., and Mark G. Edwards were elected as Class I directors to serve until the 2021 Annual Meeting.
- Adrian Adams: 15,342,296 For; 204,640 Withheld; 27,195,606 Broker Non-Votes.
- Richard Afable, M.D.: 15,383,306 For; 163,630 Withheld; 27,195,606 Broker Non-Votes.
- Mark G. Edwards: 15,340,957 For; 205,979 Withheld; 27,195,606 Broker Non-Votes.
- Proposal No. 2 (Ratification of Auditors): The selection of OUM & Co. LLP as the independent registered public accounting firm for the year ending December 31, 2018, was ratified.
- For: 42,231,884
- Against: 381,229
- Abstain: 129,429
Stephen J. Hoffman, M.D., Ph.D., and Pamela P. Palmer, M.D., Ph.D., continue as directors until 2019. Howard B. Rosen and Mark Wan continue as directors until 2020.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation that OUM & Co. LLP is the newly ratified auditor for the fiscal year ending December 31, 2018.
- Verification of the high number of broker non-votes (27,195,606) on the director election, indicating shares held by brokers that were not voted due to lack of instructions.
- Review of the full composition of the Board of Directors following the election of the Class I directors.